|
PRINT COMPANY INFORMATION
| Market Information: |
| Last Trade: |
13.90 |
| Last Update |
May 22, 2013 at 05:06PM |
| Change |
|
| |
|
| Open Price |
14.1 |
| Adjusted Open Price |
14.1 |
| Yesterday Close Price |
14.1 |
|
| |
| Close Price |
13.7 |
| |
|
| Day's Range |
13.7 - 14.8 |
| |
|
| Volume |
222000 |
| |
|
| Total Trade |
206 |
| |
|
| Market Cap in BDT* |
3257.1 (mn) |
|
| |
|
|
|
| Basic Information: |
|
|
|
| Authorized Capital in BDT* (mn) |
3000.0 |
|
|
| Paid-up
Capital in BDT* (mn) |
2310.0 |
52 Week's Range |
12.1 - 31.9 |
| |
|
|
|
| Face Value |
10.0 |
Market Lot |
500 |
| |
|
|
|
| Total no. of Securities |
231000000 |
Business Segment |
Pharmaceuticals & Chemicals |
|
VIEW CLOSE PRICE GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
VIEW TOTAL TRADES GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
| Last AGM Held: 23/12/2012 |
| Bonus Issue |
5% 2011 |
| |
|
| Right Issue |
|
| |
|
| Year End |
201206 |
| |
|
| Reserve & Surplus in BDT* (mn) |
454.13 |
|
| Interim
Financial Performance: 2013 |
Particulars |
Unaudited
/ Audited |
| Q1(3 Months)
|
Q2(6 Months)
|
Q3(9 Months)
|
Q4 (12 Months)
|
|
201209 |
201212 |
201303 |
|
Turn Over in BDT* (mn)
|
266.11 |
564.71 |
924.26 |
n/a |
Net Profit After Tax in BDT *(mn) (Continuing Operations)
|
5 |
1.93 |
5.33 |
n/a |
| Net
Profit After Tax in BDT *(mn)
(Including Extra-ordinary Income) |
0 |
0 |
0 |
n/a |
Basic EPS in BDT*
(Based on continuing operations) |
0.020 |
0.010 |
0.020 |
n/a |
Diluted EPS in BDT* (Based on continuing
operations) |
|
0.000 |
0.000 |
0.000 |
n/a |
Basic
EPS in BDT*
(Including Extra-ordinary Income) |
0.000 |
0.000 |
0.000 |
n/a |
Diluted EPS in BDT* (Including Extra-ordinary Income) |
|
0.000 |
0.000 |
0.000 |
n/a |
|
Profit Status :
| |
Basic |
Diluted |
Current Price Earning Ratio (P/E)
(Based on Continuing operation)
|
513.75 |
|
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
|
* Note - Based on Annualized
EPS of 2013 (Q3)
Price Earning Ratio Based
on last Audited Financials:
Current Price Earning Ratio (P/E)
(Based on Continuing Operation)
|
41.52 |
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
* Note - Based on
audited EPS of 2012
| Year |
Basic
EPS |
Basic
EPS (restated) |
Net Asset Value Per Share |
Restated
Net Asset Value Per Share |
Net Profit After Tax (mn) |
| Based on |
Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
Continuing operations |
Including Extra-Ordinary
Income |
Continuing operations |
Including Extra-Ordinary
Income |
| 2000 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
| 2001 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
| 2002 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
| 2003 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
| 2004 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
| 2005 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
| 2006 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
| 2007 |
-0.67 |
n/a |
n/a |
n/a |
9.32 |
n/a |
-40.49 |
n/a |
| 2008 |
-0.29 |
n/a |
n/a |
n/a |
9.04 |
n/a |
-17.18 |
n/a |
| 2009 |
0.31 |
n/a |
n/a |
n/a |
16.05 |
n/a |
18.33 |
n/a |
| 2010 |
0.11 |
n/a |
n/a |
n/a |
11.76 |
n/a |
24.11 |
n/a |
| 2011 |
0.51 |
n/a |
0.48 |
n/a |
12.22 |
11.64 |
111.60 |
n/a |
| 2012 |
0.33 |
n/a |
n/a |
n/a |
11.88 |
n/a |
75.26 |
n/a |
|
|
All figures in BDT (Bangladeshi Taka) |
| Financial Performance (Continue): |
| Year |
Year End P/E |
% Dividend |
% Dividend Yield |
| Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
| 2000 |
n/a |
n/a |
n/a |
n/a |
| 2001 |
n/a |
n/a |
n/a |
n/a |
| 2002 |
n/a |
n/a |
n/a |
n/a |
| 2003 |
n/a |
n/a |
n/a |
n/a |
| 2004 |
n/a |
n/a |
n/a |
n/a |
| 2005 |
n/a |
n/a |
n/a |
n/a |
| 2006 |
n/a |
n/a |
n/a |
n/a |
| 2007 |
n/a |
n/a |
n/a |
n/a |
| 2008 |
n/a |
n/a |
n/a |
n/a |
| 2009 |
n/a |
n/a |
n/a |
n/a |
| 2010 |
n/a |
n/a |
n/a |
n/a |
| 2011 |
66.88 |
n/a |
5%B |
- |
| 2012 |
57.88 |
n/a |
- |
- |
|
| Details of Financial Statement |
|
| Price Sensitive Information |
|
| Other Information of the Company: |
| Listing Year |
2010 |
| |
|
| Market Category |
Z |
| |
|
| Electronic Share |
Y |
| |
|
| Share Percentage: |
| Sponsor/Director 30 |
Govt.0 |
Institute 18.89 |
Foreign 0 |
Public 51.11 |
|
| Remark |
Tk 348,772,688 Revaluation Surplus has been added to Reserve & Surplus. |
|
| Address of the Company: |
| Address: |
153-154, Tejgaon I/A, Dhaka-1208 |
| |
|
| Contact Phone: |
+880-2-8870133, +880-2-8870134 |
| |
|
| Fax: |
+880-2-8870131, 8870109 |
| |
|
| E-mail: |
beacon@beacon-pharma.com, beacon-ph |
| Web Address: |
http://www.beacon-pharma.com
|
|
* BDT - Bangladeshi Taka
STOCK EXCHANGE BUILDING, 9/F MOTIJHEEL C/A, DHAKA BANGLADESH
Phone: 88-02-9564601, 7175703-11, FAX: +88-02-9564727
Email: dse@bol-online.com, Web: http://www.dsebd.org/
|
 |